Investigational Drug Information for Amdoxovir
✉ Email this page to a colleague
What is the drug development status for Amdoxovir?
Amdoxovir is an investigational drug.
There have been 5 clinical trials for Amdoxovir.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2012.
The most common disease conditions in clinical trials are HIV Infections, Acquired Immunodeficiency Syndrome, and Virus Diseases. The leading clinical trial sponsors are RFS Pharma, LLC, National Institute of Allergy and Infectious Diseases (NIAID), and [disabled in preview].
Summary for Amdoxovir
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 2,569 |
| WIPO Patent Applications | 1,234 |
| Japanese Patent Applications | 556 |
| Clinical Trial Progress | Phase 2 (2012-12-01) |
| Vendors | 22 |
Recent Clinical Trials for Amdoxovir
| Title | Sponsor | Phase |
|---|---|---|
| A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects | RFS Pharma, LLC | Phase 2 |
| A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects. | RFS Pharma, LLC | Phase 2 |
| Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV | RFS Pharma, LLC | Phase 1/Phase 2 |
Clinical Trial Summary for Amdoxovir
Top disease conditions for Amdoxovir
Top clinical trial sponsors for Amdoxovir
US Patents for Amdoxovir
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
